Who owns AbbVie (ABBV)? Superinvestor holders

15 superinvestors of the 157 tracked here hold AbbVie (ABBV) in their latest 13F filing, with $5.1B between them. Fred DiSanto gives it the most weight: 1.46% of the reported portfolio.

Paul Tudor Jones sold out of it in their latest quarter.

Hold it now
15
of 157 tracked
Combined value
$5.1B
Bought / sold
6 / 9
last quarter

Key facts

Superinvestors holding it
15 of 157
Biggest holder
Ken Fisher, $2.6B
Largest weight
Fred DiSanto, 1.46%of their portfolio
Combined value
$5.1B
Bought last quarter
6
Sold last quarter
9

From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.

Superinvestors holding ABBV, latest filings
#InvestorShare of their portfolioValueSharesLast quarterShares movedQuarter
1Fred DiSantoAncora1.46%$75.6M300.56K▼ Reduced 5.4%−17.02KQ2 2026
2Ken FisherFisher Investments0.76%$2.6B10.06M▲ Added 6.0%+565.15KQ3 2026
3Larry RobbinsGlenview Capital Management0.75%$37.5M148.91KNew+148.91KQ2 2026
4Ken GriffinCitadel Advisors0.46%$797.6M3.17M▲ Added 547%+2.68MQ2 2026
5David Shaw (founder)D. E. Shaw & Co.0.33%$529M2.1M▲ Added 212%+1.43MQ2 2026
6Israel EnglanderMillennium Management0.26%$381.6M1.52M▲ Added 124%+840.71KQ2 2026
7Cliff AsnessAQR Capital Management0.18%$507.1M2.02M▲ Added 127%+1.13MQ2 2026
8Lew SandersSanders Capital0.12%$121M462.72K▼ Reduced 4.4%−21.25KQ3 2026
9Mairs & Power teamMairs & Power0.11%$11.5M43.81K▼ Reduced 2.0%−890Q3 2026
10Jensen teamJensen Investment Management0.07%$2.2M8.24K▼ Reduced 26%−2.82KQ3 2026
11Murray StahlHorizon Kinetics0.06%$4.7M17.94K▼ Reduced 5.0%−944Q3 2026
12Thomas RussoGardner Russo & Quinn0.04%$3.2M12.41KNo change0Q3 2026
13Howard GleicherAristotle Capital Management0.04%$16.5M63.15K▼ Reduced 1.3%−812Q3 2026
14Rajiv JainGQG Partners0.01%$5.6M21.3K▼ Reduced 99%−1.9MQ3 2026
15Bill NygrenHarris Associates (Oakmark)0.00%$609K2.42K▼ Reduced 9.8%−262Q2 2026

Sold out last quarter

Quarter by quarter

Superinvestor ownership of ABBV by quarter
QuarterFilings inHoldersCombined sharesCombined valueBoughtSold
Q3 202692810.69M$2.8B16
Q2 20261571521.31M$5.4B79
Q1 20261571010.24M$2.2B26
Q4 202515791.66M$378.8M210
Q3 2025157168.97M$2.1B313
Q2 20251571611.34M$2.1B113
Q1 2025156134.31M$903.4M49
Q4 2024156166.36M$1.1B69

A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.

Each holder's shares

Shares of ABBV held by each superinvestor, by quarter
InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Ken Fisher10.06M9.5M9.09M628.34K————
Lew Sanders462.72K483.96K516.59K532.16K548.32K549.14K548.76K552.52K
Howard Gleicher63.15K63.96K64.15K65.97K65.92K66.91K66.98K66.62K
Mairs & Power team43.81K44.7K45.32K46.46K47.42K47.07K41.96K45.77K
Rajiv Jain21.3K1.92M——————
Murray Stahl17.94K18.89K19.21K19.54K20.35K23.71K24.16K26.05K
Thomas Russo12.41K12.41K12.41K12.41K12.41K12.41K12.41K12.41K
Jensen team8.24K11.06K11.14K11.14K18.12K22.23K22.23K22.23K
Ken Griffin·3.17M——3.11M3.25M1.85M—
David Shaw (founder)·2.1M——1.12M1.54M——
Cliff Asness·2.02M—————1.45M
Israel Englander·1.52M——2.02M2.45M——
Fred DiSanto·300.56K317.57K338.93K340.35K345.76K344.03K350.64K
Larry Robbins·148.91K——————
Bill Nygren·2.42K2.68K2.68K3.16K3.16K——
Paul Tudor Jones·—161.05K——330.87K——
Jim Simons (1938–2024)————928.07K1.96M1.22M972.89K
Steve Cohen·———359.44K———
Ray Dalio (founder)·———260.69K598.29K—286.36K
Temasek————67.97K42.47K42.47K42.47K
Louis Bacon————60K100K45K—
John Rogers——————84.39K151.75K
Dodge & Cox team——————10.47K—
Brandon Haley·——————1.11M
Diamond Hill team———————1.01M
Doug Silverman———————260K
Richard Pzena———————1.67K

A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.

Questions and answers

Which superinvestors own ABBV?

In their latest 13F filings: Fred DiSanto (1.46% of the portfolio, $75.6M), Ken Fisher (0.76% of the portfolio, $2.6B), Larry Robbins (0.75% of the portfolio, $37.5M), Ken Griffin (0.46% of the portfolio, $797.6M), David Shaw (founder) (0.33% of the portfolio, $529M), Israel Englander (0.26% of the portfolio, $381.6M), Cliff Asness (0.18% of the portfolio, $507.1M), Lew Sanders (0.12% of the portfolio, $121M), and 7 more.

Who bought ABBV last quarter?

Ken Fisher (added 6.0%), Larry Robbins (new position), Ken Griffin (added 547%), David Shaw (founder) (added 212%), Israel Englander (added 124%), Cliff Asness (added 127%). “Last quarter” is each investor's latest reported quarter.

Who sold ABBV last quarter?

Reduced: Fred DiSanto (5.4% fewer shares), Lew Sanders (4.4% fewer shares), Mairs & Power team (2.0% fewer shares), Jensen team (26% fewer shares), Murray Stahl (5.0% fewer shares), Howard Gleicher (1.3% fewer shares), Rajiv Jain (99% fewer shares), Bill Nygren (9.8% fewer shares). Sold out entirely: Paul Tudor Jones (was $35M).

How current is this?

It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.

Learn

Cite this page

Funkfolio, “Who owns AbbVie (ABBV)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/ABBV/superinvestors

Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.

Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to ABBV by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.